May 3, 2016
The U.S. Food and Drug Administration (FDA) has concluded a review on the safety of medical marijuana, and the U.S. Drug Enforcement Administration (DEA) has announced plans to reconsider its restrictive Schedule I designation that makes the plant a controlled substance.